Mavacamten will lower the extent or influence of ethinylestradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten may decrease systemic exposures of ethinyl estradiol and progestin, which can cause contraceptive failure or an increase in breakthrough bleeding. https://alexisj543uhu7.buyoutblog.com/profile